Evolving options and future challenges f
Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer
โ
Josรฉ Baselga
๐
Article
๐
2008
๐
Elsevier Science
๐
English
โ 202 KB